Modeling cholera outbreaks

Current Topics in Microbiology and Immunology

Volumn 379, Issue , 2014, Pages 195-209

  Chao, Dennis L ^a   Longini Jr , Ira M ^b   Morris Jr , J Glenn ^b  

^a USA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ASYMPTOMATIC INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; CALIBRATION; CHOLERA; CONFERENCE PAPER; DISEASE SIMULATION; ENDEMIC DISEASE; EPIDEMIC; HAITI; HOUSEHOLD; HUMAN; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; MATHEMATICAL MODEL; MORTALITY; NONHUMAN; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; VACCINATION; VIBRIO CHOLERAE;

CHOLERA; DISEASE OUTBREAKS; HAITI; HUMANS; MODELS, THEORETICAL;

EID: 84904401641     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82-2013-307     Document Type: Conference Paper

References (85)

1. Abrams JY, Copeland JR, Tauxe RV, Date KA, Belay ED, Mody RK, Mintz ED (2012) Realtime modelling used for outbreak management during a cholera epidemic, Haiti, 2010-2011. Epidemiol Infect, pp 1-10 (in press)
2. Albert MJ, Neira M, Motarjemi Y (1997) The role of food in the epidemiology of cholera. World Health Stat Q 50(1-2):111-118
3. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: A reanalysis. Lancet 366(9479):44-49
4. Ali M, Emch M, Yunus M, Sack D, Lopez AL, Holmgren J, Clemens J (2008) Vaccine protection of Bangladeshi infants and young children against cholera: Implications for vaccine deployment and person-To-person transmission. Pediatr Infect Dis J 27(1):33-37. doi:00006454-200801000-00007[pii]
5. Andrews JR, Basu S (2011) Transmission dynamics and control of cholera in Haiti: An epidemic model. Lancet 377(9773):1248-1255. doi:10.1016/S0140- 6736(11)60273-0
6. Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, Bhuiyan MS, Rahman MA, Khanam F, Saha A, Charles RC, Larocque RC, Weil AA, Clements JD, Holmes RK, Calderwood SB, Harris JB, Ryan ET, Qadri F (2012) Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol 19(8):1304-1311. doi:10.1128/CVI.00196-12
7. Azman AS, Luquero FJ, Rodrigues A, Palma PP, Grais RF, Banga CN, Grenfell BT, Lessler J (2012) Urban cholera transmission hotspots and their implications for reactive vaccination: Evidence from Bissau City, Guinea Bissau. PLoS Negl Trop Dis 6(11):e1901. doi:10.1371/journal.pntd.0001901
8. Bengtsson L, Lu X, Thorson A, Garfield R, von Schreeb J (2011) Improved response to disasters and outbreaks by tracking population movements with mobile phone network data: A postearthquake geospatial study in Haiti. PLoS Med 8(8):e1001,083. doi:10.1371/journal.pmed.1001083
9. Bertuzzo E, Casagrandi R, Gatto M, Rodriguez-Iturbe I, Rinaldo A (2010) On spatially explicit models of cholera epidemics. J R Soc Interf 7(43):321-333. doi:10.1098/rsif.2009.0204
10. Bertuzzo E, Mari L, Righetto L, Gatto M, Casagrandi R, Blokesch M, Rodriguez-Iturbe I, Rinaldo A (2011) Prediction of the spatial evolution and effects of control measures for the unfolding Haiti cholera outbreak. Geophys Res Lett 38:L06,403
11. Black RE, Levine MM, Clements ML, Young CR, Svennerholm AM, Holmgren J (1987) Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun 55(5):1116-1120
12. Brisson M, Edmunds WJ (2003) Economic evaluation of vaccination programs: The impact of herd-immunity. Med Decis Making 23(1):76-82
13. Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22(19):2444-2451
14. Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB (1974) Response of man to infection with Vibrio cholerae. I. clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis 129(1):45-52
15. Centers for Disease Control and Prevention (CDC). 2010) Update: Cholera outbreak-Haiti, 2010. MMWR Morb Mortal Wkly Rep 59 45 1473-1479
16. Chaignat CL, Monti V (2007) Use of oral cholera vaccine in complex emergencies: What next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr 25(2):244-261
17. Chao DL, Halloran ME, Longini IM Jr (2011) Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc Natl Acad Sci U S A 108(17):7081-7085. doi:10.1073/pnas.1102149108
18. Chunara R, Andrews JR, Brownstein JS (2012) Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak. Am J Trop Med Hyg 86(1):39-45. doi:10.4269/ajtmh.2012.11-0597
19. Clemens JD (2011) Vaccines in the time of cholera. Proc Natl Acad Sci U S A 108(21):8529-8530. doi:10.1073/pnas.1105807108
20. Codeco CT (2001) Endemic and epidemic dynamics of cholera: The role of the aquatic reservoir. BMC Infect Dis 1:1
21. Connolly, MA (eds) (2005) Communicable disease control in emergencies: A field manual. World Health Organization, Geneva
22. Cook J, Jeuland M, Maskery B, Lauria D, Sur D, Clemens J, Whittington D (2009) Using private demand studies to calculate socially optimal vaccine subsidies in developing countries. J Policy Anal Manage 28(1):6-28
23. Cravioto A, Lanta CF, Lantagne DS, Nair GB (2011) Final report of the independent panel of experts on the cholera outbreak in Haiti. United Nations, New York
24. Farmer P, Almazor CP, Bahnsen ET, Barry D, Bazile J, Bloom BR, Bose N, Brewer T, Calderwood SB, Clemens JD, Cravioto A, Eustache E, Jérome G, Gupta N, Harris JB, Hiatt HH, Holstein C, Hotez PJ, Ivers LC, Kerry VB, Koenig SP, LaRocque RC, Léandre F, Lambert W, Lyon E, Mekalanos JJ, Mukherjee JS, Oswald C, Pape JW, Gretchko Prosper A, Rabinovich R, Raymonville M, Réjouit JR, Ronan LJ, Rosenberg ML, Ryan ET, Sachs JD, Sack DA, Surena C, Suri AA, Ternier R, Waldor MK, Walton D, Weigel JL (2011) Meeting cholera's challenge to Haiti and the world: A joint statement on cholera prevention and care. PLoS Negl Trop Dis 5(5):e1145. doi:10.1371/journal.pntd.0001145
25. Fox JP, Elveback L, Scott W, Gatewood L, Ackerman E (1971) Herd immunity: Basic concept and relevance to public health immunization practices. Am J Epidemiol 94(3):179-189
26. Franco AA, Fix AD, Prada A, Paredes E, Palomino JC, Wright AC, Johnson JA, McCarter R, Guerra H, Morris JG Jr (1997) Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol 146(12):1067-1075
27. Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N (2011) Mathematical models in the evaluation of health programmes. Lancet 378(9790):515-525. doi:10.1016/S0140-6736(10)61505-X
28. Global Task Force on Cholera Control (2010) Oral cholera vaccines in mass immunization campaigns: Guidance for planning and use. World Health Organization, Geneva, http://whqlibdoc.who.int/publications/2010/9789241500432- eng.pdf
29. Grad YH, Miller JC, Lipsitch M (2012) Cholera modeling: Challenges to quantitative analysis and predicting the impact of interventions. Epidemiology 23(4):523-530. doi:00001648-201207000-00004
30. Halloran ME, Longini IM Jr, Struchiner CJ (1999) Design and interpretation of vaccine field studies. Epidemiol Rev 21(1):73-88
31. Harris JB, LaRocque RC, Chowdhury F, Khan AI, Logvinenko T, Faruque ASG, Ryan ET, Qadri F, Calderwood SB (2008) Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis 2(4):e221
32. Hartley DM, Morris JG Jr, Smith DL (2006) Hyperinfectivity: A critical element in the ability of V cholerae to cause epidemics. PLoS Med 3(1):e7
33. Hethcote HW (2000) The mathematics of infectious diseases. SIAM Rev 42(4):599-653
34. Hill AN, Longini IM Jr (2003) The critical vaccination fraction for heterogeneous epidemic models. Mathematical Biosciences 181:85-106
35. Holmgren J (2012) A case for control of cholera in Africa by vaccination. Lancet Infect Dis 12(11):818-819. doi:10.1016/S1473-3099(12)70204-9
36. Hutubessy R, Henao AM, Namgyal P, Moorthy V, Hombach J (2011) Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal. BMC Med 9:55. doi:10.1186/1741-7015-9-55
37. International Vaccine Institute (2012) An investment case for the accelerated introduction of oral cholera vaccines. International Vaccine Institute, Seoul. http://www.ivi.int/publication/IVI-Global-cholera-case.pdf
38. Ivers LC, Farmer P, Almazor CP, Léandre F (2010) Five complementary interventions to slow cholera: Haiti. Lancet 376(9758):2048-2051. doi:10.1016/S0140-6736(10)62243-X
39. Jeuland M, Cook J, Poulos C, Clemens J, Whittington D (2009) Cost-effectiveness of newgeneration oral cholera vaccines: A multisite analysis. Value Health 12(6):899-908
40. Kendall EA, Chowdhury F, Begum Y, Khan AI, Li S, Thierer JH, Bailey J, Kreisel K, Tacket CO, LaRocque RC, Harris JB, Ryan ET, Qadri F, Calderwood SB, Stine OC (2010) Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis. J Bacteriol 192(17):4367-4376. doi:10.1128/JB.00698-10
41. Kermack WO, McKendrick AG (1927) A contribution to the mathematical theory of epidemics. Proc Roy Soc Lon Ser A 115:700-721
42. Khan K, McNabb SJ, Memish ZA, Eckhardt R, Hu W, Kossowsky D, Sears J, Arino J, Johansson A, Barbeschi M, McCloskey B, Henry B, Cetron M, Brownstein JS (2012) Infectious disease surveillance and modelling across geographic frontiers and scientific specialties. Lancet Infect Dis 12(3):222-230
43. Kim SY, Choi Y, Mason PR, Rusakaniko S, Goldie SJ (2011) Potential impact of reactive vaccination in controlling cholera outbreaks: An exploratory analysis using a Zimbabwean experience. S Afr Med J 101(9):659-664
44. King AA, Ionides EL, Pascual M, Bouma MJ (2008) Inapparent infections and cholera dynamics. Nature 454(7206):877-880
45. Koch R (1886) Further researches on cholera. Br Med J 1(1306):62-66
46. Koch R (1893) Ueber den augenblicklichen Stand der bakteriologischen Choleradiagnose. Medical Microbiology and Immunology 14:319-338
47. Koelle K, Pascual M (2004) Disentangling extrinsic from intrinsic factors in disease dynamics: A nonlinear time series approach with an application to cholera. Am Nat 163(6):901-913
48. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G (2005) Refractory periods and climate forcing in cholera dynamics. Nature 436(7051):696-700
49. Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B (1999) Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 77(10):837-842
50. Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, Khanam F, Uddin T, Riyadh MA, Saha A, Alam MM, Chowdhury F, Khan AI, Charles R, Larocque R, Harris JB, Calderwood SB, Qadri F, Ryan ET (2012) Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol 19(5):690-698. doi:10.1128/CVI.05615-11
51. Levine MM, Nalin DR, Rennels MB, Hornick RB, Sotman S, Van Blerk G, Hughes TP, O'Donnell S, Barua D (1979) Genetic susceptibility to cholera. Ann Hum Biol 6(4):369-374
52. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4(11):e336
53. Mari L, Bertuzzo E, Righetto L, Casagrandi R, Gatto M, Rodriguez-Iturbe I, Rinaldo A (2012) Modelling cholera epidemics: The role of waterways, human mobility and sanitation. J R Soc Interf 9(67):376-388. doi:10.1098/rsif.2011. 0304
54. Martin S, Costa A, Perea W (2012) Stockpiling oral cholera vaccine. Bull World Health Organ 90(10):714. doi:BLT.12.112433
55. McCormack WM, Chowdhury AM, Jahangir N, Ahmed AB, Mosley WH (1968) Tetracycline prophylaxis in families of cholera patients. Bull World Health Organ 38(5):787-792
56. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, Calderwood SB, Schoolnik GK, Camilli A (2002) Host-induced epidemic spread of the cholera bacterium. Nature 417(6889):642-645
57. Miller Neilan RL, Schaefer E, Gaff H, Fister KR, Lenhart S (2010) Modeling optimal intervention strategies for cholera. Bull Math Biol 72(8):2004-2018. doi:10.1007/s11538-010-9521-8
58. Morris JG Jr (2011) Cholera-modern pandemic disease of ancient lineage. Emerg Infect Dis 17(11):2099-2104. doi:10.3201/eid1711.111109
59. Mosley WH, Alvero MG, Joseph PR, Tamayo JF, Gomez CZ, Montague T, Dizon JJ, Henderson DA (1965) Studies of cholera El Tor in the Philippines. 4. Transmission of infection among neighbourhood and community contacts of cholera patients. Bull World Health Organ 33(5):651-660
60. Mosley WH, Ahmad S, Benenson AS, Ahmed A (1968) The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ 38(5):777-785
61. Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, Morris JG Jr (2011) Estimating the reproductive numbers for the 2008-2009 cholera outbreaks in Zimbabwe. Proc Natl Acad Sci U S A 108(21):8767-8772. doi:10.1073/pnas. 1019712108
62. Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, Clemens JD (1998) Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: A cost-effectiveness analysis. JAMA 279(7):521-525
63. Nelson EJ, Harris JB, Morris JG Jr, Calderwood SB, Camilli A (2009) Cholera transmission: The host, pathogen and bacteriophage dynamic. Nat Rev Microbiol 7(10):693-702
64. Palit A, Batabyal P, Kanungo S, Sur D (2012) In-house contamination of potable water in urban slum of Kolkata, India: A possible transmission route of diarrhea. Water Sci Technol 66(2):299-303. doi:10.2166/wst.2012.177
65. Pascual M, Koelle K, Dobson AP (2006) Hyperinfectivity in cholera: A new mechanism for an old epidemiological model. PLoS Med 3(6):e280
66. Rabbani GH, Greenough WB 3rd (1999) Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res 17(1):1-9
67. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L (2011) The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis 5(1):e952. doi:10.1371/journal.pntd.0000952
68. Rinaldo A, Bertuzzo E, Mari L, Righetto L, Blokesch M, Gatto M, Casagrandi R, Murray M, Vesenbeckh SM, Rodriguez-Iturbe I (2012) Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections. Proc Natl Acad Sci U S A 109(17):6602-6607. doi:10.1073/pnas. 1203333109
69. Roberts L, Chartier Y, Chartier O, Malenga G, Toole M, Rodka H (2001) Keeping clean water clean in a Malawi refugee camp: A randomized intervention trial. Bull World Health Organ 79(4):280-287
70. Ruiz-Moreno D, Pascual M, Emch M, Yunus M (2010) Spatial clustering in the spatio-Temporal dynamics of endemic cholera. BMC Infect Dis 10:51
71. Sack DA (2003) When should cholera vaccine be used in cholera-endemic areas. J Health Popul Nutr 21(4):299-303
72. Sack DA, Sack RB, Nair GB, Siddique AK (2004) Cholera. Lancet 363(9404):223-233
73. Snow J (1855) On the mode of communication of cholera. John Churchill, London
74. Sommer A, Mosley WH (1973) Ineffectiveness of cholera vaccination as an epidemic control measure. Lancet 1(7814):1232-1235
75. St Louis ME, Porter JD, Helal A, Drame K, Hargrett-Bean N, Wells JG, Tauxe RV (1990) Epidemic cholera in West Africa: The role of food handling and high-risk foods. Am J Epidemiol 131(4):719-728
76. Stine OC, Alam M, Tang L, Nair GB, Siddique AK, Faruque SM, Huq A, Colwell R, Sack RB, Morris JG Jr (2008) Seasonal cholera from multiple small outbreaks, rural Bangladesh. Emerg Infect Dis 14(5):831-833
77. Suntharasamai P, Migasena S, Vongsthongsri U, Supanaranond W, Pitisuttitham P, Supeeranan L, Chantra A, Naksrisook S (1992) Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers. Vaccine 10(8):502-505
78. Tamayo JF, Mosley WH, Alvero MG, Joseph PR, Gomez CZ, Montague T, Dizon JJ, Henderson DA (1965) Studies of cholera El Tor in the Philippines. Transmission of infection among household contacts of cholera patients. Bull World Health Organ 33(5):645-649
79. Tien JH, Earn DJD (2010) Multiple transmission pathways and disease dynamics in a waterborne pathogen model. Bull Math Biol 72(6):1506-1533. doi:10.1007/s11538-010-9507-6
80. Tuite AR, Tien J, Eisenberg M, Earn DJD, Ma J, Fisman DN (2011) Cholera epidemic in Haiti, 2010: Using a transmission model to explain spatial spread of disease and identify optimal control interventions. Ann Intern Med 154(9):593-601. doi:10.1059/0003-4819-154-9-201105030-00334
81. Waldor MK, Hotez PJ, Clemens JD (2010) A national cholera vaccine stockpile-A new humanitarian and diplomatic resource. N Engl J Med 363(24):2279-2282. doi:10.1056/NEJMp1012300
82. Walton DA, Ivers LC (2011) Responding to cholera in post-earthquake Haiti. N Engl J Med 364(1):3-5. doi:10.1056/NEJMp1012997
83. Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque ASG, Ryan ET, Calderwood SB, Qadri F, Harris JB (2009) Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis 49(10):1473-1479. doi:10.1086/644779
84. World Health Organization (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85(13):117-128
85. World Health Organization. 2012) Meeting report of the WHO Technical Working Group on creation of an oral cholera vaccine stockpile World Health Organization, Geneva..